Alzheimer s & DementiaNeurosciencePeer-reviewed journal article
Tau-mediated synaptic dysfunction is coupled with HCN channelopathy
Despoina GoniotakiiD, Francesco TamagniniiD, Luca BiasettiiD, Svenja-Lotta RumpfiD, Claire TroakesiD, Saskia J. PollackiD, Shalom Ukwesa, Haoyue Sun, Igor KraeviD, Louise C. SerpelliD, Wendy J. NobleiD, Kevin StarasiD, Diane P. HangeriD
- Citations
- 10
- FWCI
- 1.98
- Field percentile
- top 14%
Abstract
Progressive neurodegeneration in tauopathies is mediated through an elusive mechanism. Here, we show that hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are functionally linked to disease-associated abnormalities in tau. Selective rises in the proportion of HCN-positive neurons are detected both in post-mortem human brain from Alzheimers disease and in the Tau35 mouse model of tauopathy. Tau35 mice develop progressive abnormalities including increased phosphorylated tau, enhanced HCN channel expression and decreased dendritic branching, as well as reduced synapse density that is accompanied by vesicle clustering defects. Notably, altered spine density and increased HCN channel expression in Tau35 neurons correlates with functional abnormalities in network properties, including enhanced hyperpolarization-induced membrane voltage sag and changes in the frequency and kinetics of spontaneous excitatory postsynaptic currents. Our findings are consistent with pathological changes in tauopathies impacting on HCN channels to drive network-wide structural and functional synaptic deficits, providing new targets for therapeutic intervention.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimers Disease
Louis John Kolling, Nagalakshmi Balasubramanian, … Catherine Anne Marcinkiewcz·Alzheimer s & DementiaPeer-reviewed·May 1, 2026
- Pharmacological potentiation of Nav1.1 channels in interneurons mitigates tau depositions and neuronal death in a mouse model of neurodegenerative dementias
Kazuaki Sampei, Junya Hirokawa, … Masafumi Shimojo·bioRxiv·Aug 20, 2025
- Tau drives cell specific functional isolation of the hippocampal formation
Theodore J. Zwang, Jasen Zhang, … Bradley T. Hyman·bioRxiv·Aug 10, 2025
- BDNF and TRiC-inspired Reagents Rescue Cortical Synaptic Deficits in a Mouse Model of Huntington's Disease
Yingli Gu, Alexander Pope, … Chengbiao Wu·Neurobiology of DiseasePeer-reviewed·Apr 10, 2024
- Hypothalamic MCH neurons links tau pathology to sleep disruption
Ke Pang, Siyin Guo, … Peng Zhong·bioRxiv·Jun 3, 2026
- Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy
Changyi Ji, Xiaofeng Yang, … Einar M. Sigurdsson·Alzheimer s & DementiaPeer-reviewed·Oct 5, 2024